Adempas Tablets and Bictegravir, emtricitabine, and tenofovir
Determining the interaction of Adempas Tablets and Bictegravir, emtricitabine, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: bictegravir / emtricitabine / tenofovir alafenamide
Brand name: Biktarvy
Synonyms: Bictegravir, Emtricitabine, and Tenofovir Alafenamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Bictegravir, Emtricitabine, and Tenofovir Alafenamide
- Adempas Tablets-Bidex-A
- Adempas Tablets-BiDil
- Adempas Tablets-Bifera
- Adempas Tablets-BiferaRx
- Adempas Tablets-Bijuva
- Bictegravir, emtricitabine, and tenofovir-Adenocard
- Bictegravir, emtricitabine, and tenofovir-Adenoscan
- Bictegravir, emtricitabine, and tenofovir-Adenosine
- Bictegravir, emtricitabine, and tenofovir-Adenosine Intravenous
- Bictegravir, emtricitabine, and tenofovir-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Bictegravir, emtricitabine, and tenofovir-Adenovirus Vaccine